Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? the LInköping Study on Thrombosis (LIST) - A 7-year follow-up

Thrombosis Research

Volumn 131, Issue 2, 2013, Pages 135-139

  Chaireti, Roza ^a,b   Jennersjö, Cecilia ^a   Lindahl, Tomas L ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Recurrence; Thrombin generation; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

BIOLOGICAL MARKERS; COHORT STUDIES; FACTOR V; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; THROMBIN; THROMBOEMBOLISM; TIME FACTORS;

EID: 84872282264     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.11.015     Document Type: Article

References (37)

1. T. Baglin, R. Luddington, and K. Brown High risk of recurrent venous thromboembolism in men J Thromb Haemost 2 2004 2152 2155
2. S.C. Christiansen, S.C. Cannegieter, and T. Koster Thrombophilia, clinical factors, and recurrent venous thrombotic events JAMA 293 2005 2352 2361
3. S.Z. Goldhaber Prevention of recurrent idiopathic venous thromboembolism Circulation 110 Suppl. IV 2004 IV-20 IV-24
4. J.A. Heit Venous thromboembolism: disease burden, outcomes and risk factors J Thromb Haemost 3 8 2005 1611 1617
5. G. Palareti, and B. Cosmi Predicting the risk of recurrence of venous thromboembolism Curr Opin Hematol 11 3 2004 192 197
6. M.G. Santamaria, G. Agnelli, M.R. Taliani for the warfarin Optimal Duration Italian Trial [WODIT) Investigators Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment Thromb Res 116 2005 301 306
7. P. Lindmarker, and S. Schulman The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg. The DURAC Trial Study Group J Intern Med 247 May 2000 601 606
8. P.O. Hansson, J. Sörbo, and H. Eriksson Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors Arch Intern Med 160 6 Mar 27 2000 769 774
9. S. Schulman, and M. Ogren New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism Thromb Haemost 96 2006 258 266
10. S. Eichinger, G. Heinze, and L.M. Jandeck Thrombosis or Pulmonary Embolism: The Vienna Prediction Model Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Circulation 121 2010 1630 1636
11. B. Cosmi, C. Legnani, A. Tosetto Prolong Investigators Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension J Thromb Haemost 8 Sep 2010 1933 1942
12. K. Strandberg, P.J. Svensson, and A.-K. Öhlin Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity Thromb Res 121 2007 145 151
13. J.P. Vandenbroucke, T. Koster, and E. Briet Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 26 Nov 1994 3441453 3441457
14. R.M. Bertina, B.P. Koeleman, and T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 6475 May 5 1994 64 67
15. U. Kjellberg, M. van Roojen, and K. Bremme Factor V Leiden mutation and pregnancy-related complications Am J Obstet Gynecol 203 5 Nov 2010 1 8 [469.e]
16. S. Middeltorp Is thrombophilia testing useful? Hematology Am Soc Hematol Educ Program 2011 2011 150 155
17. A. Tripodi, C. Legnani, and V. Chantarangkul Highthrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism J Thromb Haemost 6 Aug 2008 1327 1333
18. M. Besser, C. Baglin, and R. Luddington High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study J Thromb Haemost 6 2008 1720 1725
19. A. van Hylckama Vlieg, S.C. Christiansen, and R. Luddington Elevated endogenous thrombin potential is associated with an increased risk of a first deep vein thrombosis but not with the risk of recurrence Br J Haematol 138 Sept 2007 769 774
20. R. Chaireti, C. Jennersjö, and T.L. Lindahl Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study Thromb Res 124 Jun 2009 178 184
21. C. Jennersjö, I.H. Fagerberg, and S.G. Karlander Normal D-dimer concentration is a common finding in symptomatic outpatients with distal deep vein thrombosis Blood Coagul Fibrinolysis 16 Oct 2005 517 523
22. G. Lippi, G.L. Salvagno, and M. Montagnana Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma Clin Chem 52 9 2006 1827 1828
23. The Thrombogram Guide. Thrombinoscope BV®, Maastricht, the Netherlands.
24. B. Cosmi, C. Legnani, and M. Cini D-dimer and residual veinobstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis Thromb Haemost 105 5 May 3 2011 837 845
25. S. Eichinger Thrombin generation and VTE Hämostaseologie 28 Feb 2008 37
26. S. Eichinger, G. Hron, and M. Kollars Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer Clin Chem 54 Dec 2008 2042 2048
27. G. Hron, M. Kollars, and B.R. Binder Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA 296 2006 397 402
28. P. Prandoni, A.W. Lensing, and A. Cogo The long-term clinical course of acute vein thrombosis Ann Intern Med 125 1 Jul 1 1996 1 7
29. P.M. Ridker, J.P. Miletich, and M.J. Stampfer Factor V Leiden and risks for recurrent idiopathic venous thromboembolism Circulation 92 Nov 15 1995 2800 2802
30. T.L. Lindahl, T.H. Lundahl, and L. Nilsson APC-resistance Is a Risk Factor for Postoperative Thromboembolism in Elective Replacement of the Hip or Knee - A Prospective Study Thromb Haemost 81 1999 18 21
31. K. Wåhlander, G. Larson, and T.L. Lindahl Factor V Leiden (G1691A) and prothrombin gene G20210A mutations of potential risk factors for venous thromboembolism after total hip or total knee replacement therapy Thromb Haemost 87 2002 580 585
32. K. Devreese, W. Wijns, and I. Combes Thrombin generation in plasma of healthy adults and children: Chromogenic versus fluorogenic thrombogram analysis Thromb Haemost 98 2007 600 613
33. D. Chen Dorlin A Critical roles for thrombin in acute and chronic inflammation J Thromb Haemost 7 Suppl. 1 Jul 2009 122 126
34. M. Levi The coagulant response in sepsis and inflammation Hämostaseologie 30 Feb 2010 10 16
35. J. Martin, S. Coolot-Teixeira, and L. McGregor The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes Curr Pharm Des 13 17 2007 1751 1759
36. G. Dubin Proteinaceous cysteine protease inhibitors Cell Mol Life Sci 62 2005 653 669
37. K. Brummel-Ziedins, C.Y. Vossen, and F.R. Rosendaal The plasma hemostatic proteome: thrombin generation in healthy individuals J Thromb Haemost 3 2005 1472 1481